Cargando…

Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy

There are limitations on diagnostic methods to differentiate between active and latent tuberculosis (TB), and the prediction of latent progression to TB disease is yet complex. Traditionally, tuberculosis-specific host immune response was visualized using the tuberculin skin test. Nowadays, IFN-γ re...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Steenwinkel, J. E. M., de Knegt, G. J., ten Kate, M. T., Verbrugh, H. A., Ottenhoff, T. H. M., Bakker-Woudenberg, I. A. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346930/ https://www.ncbi.nlm.nih.gov/pubmed/21983896 http://dx.doi.org/10.1007/s10096-011-1428-2

Ejemplares similares

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB
por: de Steenwinkel, Jurriaan E.M., et al.
Publicado: (2012)

Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice
por: van den Berg, Sanne, et al.
Publicado: (2013)

Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases
por: Mourik, Bas C., et al.
Publicado: (2017)

Mycobacterium tuberculosis Beijing Type Mutation Frequency
por: de Steenwinkel, Jurriaan E.M., et al.
Publicado: (2013)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Evidence Supporting a Role for Mammalian Chitinases in Efficacy of Caspofungin against Experimental Aspergillosis in Immunocompromised Rats
por: Verwer, Patricia E. B., et al.
Publicado: (2013)

Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy
por: Refos, Jeannine M., et al.
Publicado: (2017)

Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv
por: Mourik, Bas C., et al.
Publicado: (2019)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis
por: Ang, M, et al.
Publicado: (2012)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Regulation of Interferon Gamma Signaling by Suppressors of Cytokine Signaling and Regulatory T Cells
por: Larkin, Joseph, et al.
Publicado: (2013)

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
por: Blount, Robert J., et al.
Publicado: (2016)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
por: Scordo, Julia M., et al.
Publicado: (2021)

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Gamma Interferon Is Required for Chlamydia Clearance but Is Dispensable for T Cell Homing to the Genital Tract
por: Helble, Jennifer D., et al.
Publicado: (2020)

Mycobacterium marinum Infection and Interferon-Gamma Release Assays Cross-Reactivity: A Case Report
por: Patel, Premalkumar M, et al.
Publicado: (2022)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

Diagnostic Performance of Interferon-Gamma Releasing Assay in HIV-Infected Patients in China
por: Yu, Yanhua, et al.
Publicado: (2013)

251 Interferon-Gamma Release Assay—Useful Tool for the Diagnosis of Pleural Tuberculosis
por: Ondrejkova, Andrea, et al.
Publicado: (2012)

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
por: Talati, Naasha J, et al.
Publicado: (2011)

Decay Kinetics of an Interferon Gamma Release Assay with Anti-Tuberculosis Therapy in Newly Diagnosed Tuberculosis Cases
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2010)

Erratum: Regulation of Interferon Gamma Signaling by Suppressors of Cytokine Signaling and Regulatory T Cells
por: Larkin, Joseph, et al.
Publicado: (2014)

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients
por: Chen, Changguo, et al.
Publicado: (2017)

Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review
por: Rahman, Samra, et al.
Publicado: (2021)

Interferon-gamma release assay performance in northeastern Brazil: influence of the IFNG + 874 A>T polymorphism
por: Carneiro, Valdirene Leão, et al.
Publicado: (2018)

Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection
por: Cattamanchi, Adithya, et al.
Publicado: (2010)

Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals
por: de Oliveira, Sandra Maria do Valle Leone, et al.
Publicado: (2017)

Interferon gamma (IFNg) drives disease in the TLR9-mediated cytokine storm syndrome in mice
por: de Min, C, et al.
Publicado: (2015)

Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening
por: Lim, R. K., et al.
Publicado: (2021)

Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion
por: Simmons, Jason D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ed1ugjidifr1sgqaceivaus3t4